As of 2026, NeuroGum, now marketed primarily as Neuro, does not have a publicly verified net-worth figure or disclosed current valuation. What can be established from credible reporting and the company itself is that the privately held functional gum and mint business has reached $102 million in annual revenue for 2025, while Neuro says its cumulative sales have reached $135 million.
The company was founded by Kent Yoshimura and Ryan Chen, two University of California, San Diego-connected friends who developed functional gum as a portable alternative to conventional energy products. Their 2020 Shark Tank appearance ended without a deal, but the business later expanded dramatically and returned to the show in 2026, when Daniel Lubetzky became a partner after previously helping the founders through a serious trademark dispute.
NeuroGum Net Worth 2026 at a Glance
| Category | Verified information |
|---|---|
| Company | Neuro / Neuro Gum |
| Legal name | Neuro Gum Inc. |
| Founders | Kent Yoshimura and Ryan Chen |
| Founded | 2015 |
| Headquarters | Las Vegas, Nevada |
| Industry | Functional gum, mints, wellness and consumer packaged goods |
| Ownership status | Privately held |
| 2025 revenue | $102 million, according to founder disclosures to Inc. |
| Cumulative sales | $135 million, reported by Neuro in its 2026 Shark Tank update |
| Current public valuation | Not disclosed |
| Earlier reported valuation | $50 million in 2024, according to Shark Tank Blog |
| Shark Tank debut | 2020 |
| Shark Tank deal in 2020 | None |
| 2026 strategic partner | Daniel Lubetzky |
| Retail footprint | 20,000+ stores in the 2026 Shark Tank update |
| @neurogum | |
| Website | Neurogum.com |
Neuro is a private company, so it does not publish the kind of audited market capitalization or detailed ownership statements available for publicly traded corporations. That makes a precise “NeuroGum net worth” number impossible to verify from public records.
What Is NeuroGum Net Worth in 2026?
The most accurate answer is that NeuroGum’s exact 2026 net worth is not publicly known. Some online articles assign the company valuations without showing a primary transaction or current financing document that would substantiate the number, so those figures should not be presented as established fact.
There is, however, meaningful financial evidence behind the company’s current scale. Inc. reported in July 2026 that Neuro generated $102 million in revenue during 2025, based on figures confirmed by the founders. Neuro itself reported $135 million in cumulative sales during its 2026 Shark Tank update.
The distinction matters. Revenue is not the same thing as net worth or company valuation. A business generating $102 million in annual revenue could be worth substantially more or less than that amount depending on margins, debt, growth rate, ownership dilution, cash flow and the terms investors are willing to accept.
NeuroGum Valuation Timeline
| Year | Financial or valuation milestone |
|---|---|
| 2019 | About $3.5 million in sales through eight months, according to the founders’ original Shark Tank-era figures |
| 2020 | Entered Shark Tank seeking $750,000 for 5%, implying a $15 million valuation |
| 2023 | Reported $8.3 million seed round |
| 2024 | Reported company valuation of approximately $50 million by Shark Tank Blog |
| 2025 | $102 million revenue, according to founder disclosures to Inc. |
| 2026 | $135 million cumulative sales, 20,000+ stores and Daniel Lubetzky partnership |
The $50 million 2024 valuation is a historical third-party report rather than a current company valuation. The earlier $15 million number was an implied valuation from the founders’ 2020 Shark Tank asking price, not a verified market value.
Who Founded NeuroGum?
NeuroGum was founded by Kent Yoshimura and Ryan Chen. Neuro’s own history says the founders were friends who developed the concept while connected to the University of California, San Diego, eventually spending years refining the formula before launching the commercial product in 2015.
Kent Yoshimura serves as co-founder and CEO, while Ryan Chen has been identified by Neuro as co-founder and CFO. Crunchbase likewise lists Yoshimura and Chen as the company’s founders and identifies Neuro Gum Inc. as the legal entity.
Kent Yoshimura
Yoshimura has a background that combines neuroscience, creative work and athletics. Neuro’s published biography says he earned a bachelor’s degree in neuroscience from UC San Diego and later worked as a multimedia creative and filmmaker while pursuing martial arts. He trained in Judo with the Japanese Olympic Judo team and also trained in Muay Thai in Thailand.
His public professional profile identifies him as co-founder and CEO of Neuro and links to Neuro’s website and his personal website. His publicly listed Instagram handle is @kentaro.
Ryan Chen
Ryan Chen is Neuro’s other co-founder and CFO. Neuro says Chen was seriously injured in a snowboarding accident at age 19, resulting in paralysis, after which he continued his education and eventually trained in racing with the U.S. Paralympic team. The company’s biography says he earned degrees in Economics and Chemistry and was recognized in Forbes 30 Under 30.
Chen’s public biography and recent podcast appearances reinforce his central role in Neuro’s development, particularly on the company’s financial and operational side. His current public Instagram is identified as @ryan.ryc.
NeuroGum Early Life and Background
The founders’ story began well before Neuro became a multimillion-dollar consumer brand. According to Neuro’s own account, Yoshimura was interested in nootropics and cognitive performance while balancing school and athletic training. Chen, meanwhile, was dealing with the consequences of his accident and rebuilding his life through education and sport.
That combination ultimately produced the company’s central idea: take compounds associated with energy and focus and place them into a form that was inexpensive, portable and convenient. Rather than building another canned energy drink, the founders decided that gum and mints could serve as a functional delivery format.
The formulation process was not quick. Yoshimura wrote that the team worked with a chemist for roughly two years and reformulated the product more than 20 times before settling on a commercially viable version. Neuro later said its formulas had been modified and tested nearly 30 times as the company continued developing its products.
How NeuroGum Makes Money
Neuro’s business model is based on selling functional gum and mints directly to consumers as well as through retail distribution.
Its product portfolio has expanded beyond the company’s original energy-focused gum. Current offerings include products positioned around energy and focus, memory and focus, calm and clarity, and sleep and recharge, although formulas and available products can change over time. Neuro’s current website also promotes both online purchases and retail availability.
Key revenue channels include:
- Direct-to-consumer sales through Neuro’s website
- Retail distribution through major national chains
- Amazon and other online marketplaces
- Subscription purchases
- Functional gum and mint product lines
- Partnerships and brand collaborations
This diversification is important to understanding Neuro’s growth. The business is no longer dependent on a single website or a single product SKU.
NeuroGum Products and Formula
Neuro’s best-known products are functional chewing gum and mints containing ingredients such as caffeine, L-theanine and B vitamins. Neuro’s published product information states that its standard Energy & Focus products contain 40 mg of natural caffeine, while an Extra Strength version contains 100 mg, with L-theanine and B vitamins also included.
The company markets the products as convenient alternatives to traditional drinks and supplements. Its messaging emphasizes portability, sugar-free formulations and the ability to consume the products without carrying a bottle or preparing a drink.
Neuro also places regulatory disclaimers on its materials. The company explicitly states that claims involving its products have not been evaluated by the U.S. Food and Drug Administration and that its products are not intended to diagnose, treat, cure or prevent disease.
NeuroGum and Shark Tank
Neuro became widely known outside its existing customer base after appearing on ABC’s Shark Tank in 2020.
Yoshimura and Chen entered seeking $750,000 for 5% equity, implying a company valuation of approximately $15 million. At the time, the founders said the company had generated about $3.5 million in sales over eight months of 2019.
Two notable offers emerged.
| Shark | Offer |
|---|---|
| Robert Herjavec | $1 million for 20%, later negotiated toward a lower equity figure |
| Kevin O’Leary | $750,000 for 5% plus a $0.50-per-unit royalty until $1 million was recovered |
| Final result | No deal |
The founders ultimately declined the offers.
At the time, that decision looked risky. In retrospect, it became one of the central pieces of Neuro’s business story because the company expanded without accepting either of those specific deals. Neuro later described its original Shark Tank experience as a turning point rather than a failure.
How Much Was NeuroGum Worth on Shark Tank?
Neuro’s 2020 asking price implied a $15 million valuation. That does not mean the company was independently worth exactly $15 million, because it was simply the valuation implied by the founders’ requested investment.
The Sharks’ reactions showed the valuation gap clearly. The founders resisted proposals they believed undervalued the company, and they ultimately walked away from the show without a deal.
That $15 million figure should therefore be treated as a historical asking valuation, not as Neuro’s present value.
NeuroGum’s Growth After Shark Tank
The company’s trajectory changed substantially after its television appearance. Shark Tank Blog reported that sales increased by more than 700% after the episode aired, while the number of retail locations climbed into the thousands.
Neuro’s own account says the years after Shark Tank included both rapid growth and one of the most serious crises in the company’s history. A trademark lawsuit threatened the young business, forcing the founders to search for a way through a potentially damaging legal fight.
Instead of disappearing, Neuro continued expanding.
By 2023, third-party reporting said the company had reached roughly 6,500 retail locations, including thousands of CVS stores, and had sold more than 50 million pieces. By 2024, it was reported to be in more than 10,000 locations and producing close to $10 million in annual revenue.
The $8.3 Million Funding Round
Neuro’s early financial strategy was unusually lean for a consumer startup.
Entrepreneur reported in 2026 that Yoshimura and Chen raised approximately $1.6 million during their first seven years while many comparable direct-to-consumer startups raised dramatically larger amounts. The founders also described years when they took little or no conventional salary because cash was continually reinvested into the company.
A separate Shark Tank-focused report states that Neuro raised approximately $8.3 million in a seed round in February 2023. That funding marked a major shift from the company’s earlier bootstrapped period.
The distinction between these figures is important. The first seven years’ roughly $1.6 million represents earlier fundraising, while the $8.3 million seed round came later as Neuro had already demonstrated substantial commercial traction.
The Trademark Lawsuit That Nearly Changed Neuro’s Future
One of Neuro’s least visible but most consequential challenges was a trademark dispute involving another company using the Neuro name.
According to Neuro’s own 2026 retrospective, the dispute became serious enough that the founders sought outside assistance from Daniel Lubetzky, the founder associated with KIND and a former Shark Tank guest. Lubetzky helped the founders navigate the dispute and reach a settlement.
The episode is notable because Lubetzky was familiar with the founders from their earlier Shark Tank appearance. He had declined to invest at the time, explaining later that he worried the company’s rapid early growth could reverse. Years later, he became formally involved with Neuro.
Daniel Lubetzky Becomes a Neuro Partner
In 2026, Daniel Lubetzky officially became a partner in Neuro.
Neuro described the relationship as the continuation of a connection that began after the company’s original Shark Tank appearance. Lubetzky’s role evolved from informal help during the legal crisis into a formal business relationship.
This became a major storyline during Neuro’s Season 17 update on Shark Tank, aired in March 2026. The company’s return attracted attention because Neuro had previously rejected offers in the Tank rather than accepting a deal.
NeuroGum Revenue in 2025 and 2026
The strongest current financial figure comes from Inc.’s July 2026 reporting.
The publication said Neuro generated $102 million in revenue during 2025, with that number confirmed by the founders. Inc. described the company as having reached nine-figure annual revenue while continuing to expand its retail footprint.
That number is particularly significant when compared with the business’s earlier scale.
| Period | Reported business scale |
|---|---|
| Early 2019 | $3.5M sales over eight months |
| 2023 | 6,500 retail locations |
| 2024 | Nearly $10M annual revenue reported; 10,000+ locations |
| 2025 | $102M annual revenue |
| 2026 | $135M cumulative sales, according to Neuro’s Shark Tank update |
The figures should not be interpreted as a smooth year-by-year revenue series because the sources use different measurement periods and definitions. Still, the broad trajectory is unmistakable: Neuro has moved from a small startup seeking $750,000 on television to a privately held consumer brand reporting nine-figure annual revenue.
How Much Money Do Kent Yoshimura and Ryan Chen Personally Have?
There is no reliable public figure for Kent Yoshimura’s personal net worth or Ryan Chen’s personal net worth.
Because Neuro is privately held, the founders’ exact equity stakes, personal compensation, stock holdings, debt obligations and realized investment proceeds are not fully disclosed in public filings. It would therefore be misleading to take the company’s revenue and simply divide it between the founders.
Likewise, a company’s valuation is not the same as the founders’ personal wealth. If an investor values a private company at a certain amount, founders can only translate that valuation into personal net worth after considering their ownership percentage, investor rights, liquidation preferences, taxes, debt and whether their shares can actually be sold.
Does NeuroGum Have a Public Valuation?
No current 2026 valuation has been publicly established through a disclosed financing transaction that can be independently verified.
The frequently cited $50 million valuation comes from reporting around 2024, while the 2020 Shark Tank pitch implied a $15 million valuation. Neither number should be presented as Neuro’s confirmed 2026 value.
The company’s 2026 financial performance suggests a potentially much larger enterprise than it was in 2024, but estimating a present valuation from revenue alone would be speculative.
NeuroGum Retail Expansion
Neuro’s retail strategy has become one of the most important parts of its growth story.
The company has reported distribution through major retailers including CVS, Walmart and Whole Foods Market. Its own current materials say the brand is available in more than 20,000 stores nationwide, while recent 2026 business coverage describes much broader future retail expansion.
Inc. reported that Neuro was on track to reach 77,000 stores, while Entrepreneur reported a figure of roughly 66,000 stores in its July 2026 feature. Because those figures represent expansion targets or differing reporting snapshots rather than a single audited store count, the more conservative confirmed company figure is the 20,000-plus stores Neuro cited in its Shark Tank update.
NeuroGum’s Social Media and Brand Strategy
Social media has played an unusually important role in Neuro’s consumer acquisition strategy.
Entrepreneur reported that the founders committed to posting on TikTok every day for a year, turning creator-driven marketing into a central component of the company’s growth strategy. The brand has also developed partnerships and visibility around athletes, entertainers and creators.
The company’s current brand positioning is broader than caffeine alone. Neuro increasingly presents gum and mints as functional everyday products associated with energy, focus, calm and performance. This repositioning allows the company to compete not only with traditional gum brands but also with energy drinks, supplements and other functional wellness products.
NeuroGum’s Current Products
Neuro’s portfolio now goes beyond the original nootropic-gum concept.
Current and recent product categories include:
- Energy & Focus
- Extra Strength Energy & Focus
- Memory & Focus
- Calm & Clarity
- Sleep & Recharge
- Functional mints alongside gum
The exact lineup changes as Neuro launches, reformulates and retires products, so the company’s current website remains the best source for its active catalog.
NeuroGum Awards and Recognition
The founders’ rise has attracted outside recognition in addition to the company’s commercial growth.
Ryan Chen is identified by Neuro as a Forbes 30 Under 30 honoree. Kent Yoshimura’s professional profile also lists recognition from the Los Angeles City Council and the U.S. Congress, although those awards relate to his broader creative work, including murals, rather than directly to Neuro.
More recent 2026 reporting has focused primarily on Neuro’s commercial performance, retail expansion and founder story rather than conventional entertainment-style celebrity status.
NeuroGum Net Worth: What Can Actually Be Verified?
The most defensible financial picture looks like this:
| Financial claim | Status |
|---|---|
| 2020 implied valuation of $15M | Verified from Shark Tank asking terms |
| $50M valuation in 2024 | Reported by Shark Tank Blog, not a current valuation |
| $8.3M seed round in 2023 | Reported by Shark Tank Blog |
| $102M revenue in 2025 | Reported by Inc. and confirmed by founders |
| $135M cumulative sales by 2026 | Reported by Neuro |
| Current 2026 company valuation | Not publicly disclosed |
| Kent Yoshimura personal net worth | Not publicly verified |
| Ryan Chen personal net worth | Not publicly verified |
This is why a responsible NeuroGum net worth 2026 article should not simply publish a large dollar figure as fact. The public record supports significant revenue, funding and growth, but it does not support a precise current net-worth number.
Personal Life and Relationships
Public reporting about Yoshimura and Chen focuses heavily on their friendship and business partnership. Neuro’s official story describes them as longtime friends whose shared experiences eventually led to the creation of the company.
There is not enough authoritative public information to responsibly provide verified spouse names, marriage dates, children or detailed romantic relationship histories for either founder. Those details should not be filled in using unsourced celebrity databases or social-media speculation.
Likewise, publicly accessible authoritative sources do not establish reliable dates of birth, exact ages or verified heights for both founders. Those fields are therefore best treated as not publicly verified rather than guessed.
Frequently Asked Questions About NeuroGum Net Worth
What is NeuroGum’s net worth in 2026?
NeuroGum, now operating as Neuro, does not have a publicly confirmed 2026 net-worth or valuation figure. The company reported $102 million in 2025 revenue, while Neuro said cumulative sales had reached $135 million by 2026.
Who owns NeuroGum?
Neuro was founded by Kent Yoshimura and Ryan Chen. The ownership structure is private, and Daniel Lubetzky officially became a partner in 2026. Public sources do not provide a complete current cap table showing each person’s exact percentage ownership.
How much was NeuroGum worth on Shark Tank?
The founders asked for $750,000 for 5%, implying a $15 million valuation in their 2020 pitch. They received offers but ultimately left without accepting a deal.
Did NeuroGum get a Shark Tank deal in 2026?
Neuro returned to Shark Tank in 2026 as an update story. The company highlighted Daniel Lubetzky becoming a partner, building on his earlier involvement with the founders after their trademark dispute.
How much revenue does NeuroGum make?
According to Inc., Neuro generated $102 million in revenue in 2025, based on figures confirmed by its founders. Neuro separately reported $135 million in cumulative sales by 2026.
Is NeuroGum still in business?
Yes. Neuro remains active in 2026 and sells functional gum and mints through its website and a growing national retail network. The company says its products are available in more than 20,000 stores nationwide, with current expansion continuing.
Also Read: Art TerKeurst Net Worth 2026 | Career, Wealth, Family and What’s Verified
1 Comment
Pingback: Quincie Cox Net Worth 2026 | Biography, Career, Husband & Earnings